Skip to content

Dr. Kjell Van Royen

Active Private limited companyfounded 2020active for 5 yearsWinkelbaan 36, 1730 AsseKBO/BCE: BE 0760.428.629

Lifetime

6 annual accounts with figures on one time axis
peak of €338,069 in 2025
€338,069▲ 2.9%
lowest -€1,745 in 2020
€247,261▲ 3.0%
peak of €243,015 in 2024
€3,000▼ 98.8%
€279,056▲ 595%
Board1 name since 2020
1 director
Documentsfilings and deeds
06-03-2026147 days before the deadline
2025micro format
Registered office moved from Asse to Mollem 18-11Dividend €487,276Equity from €243,015 to €3,000Debts from €40,166 to €279,056Cash from €140,100 to €196,482

Key points

from the 2025 annual accounts

Equity

€3,000 from €243,015 in 2024

Equity fell by 99% in 1 year.

Turnover

≈ €510,000 estimated

The micro format states no turnover.

Debts

€279,056 99% of the balance sheet
Financial debts 2%Taxes and wages 2%Other 96%

Of this, €274,720 falls due within a year.

Liquidity

0.93 was 11.06 in 2024

Short-term debts rose from €22,952 to €274,720.

Filings

6 annual accounts 1 late
AprilJune31 JulyOctober202020222024

The 2022 accounts came 21 days late. The other five were filed on time.

Position in the sector

1.1%

Lower solvency than 94% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Dr. Kjell Van Royen has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Dr. Kjell Van Royen. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 24-12-2020

Shares in 1 company,

Board & ownership

Recent changes

Registered office moved from Asse to Mollem The registered office moved from Mollemseweg 35, 1730 Asse to Winkelbaan 36, 1730 Mollem · General meeting of 21-10-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0760428629
Registered office moved from Bruges to Asse The registered office moved from Kervyndreef 38, 8200 Brugge to Mollemseweg 35, 1730 Asse · Board meeting of 10-08-2023 · Gazette deed
Incorporation Founded by · 300 shares · appointed as director · published on 24-12-2020 · Gazette deed
All 16 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Kjell Van Royen Asse €282,056 €338,069 1.1% -
Dr. Tim Wessels – Algemene Medische Oncologie Holsbeek €262,551 €314,568 7.0% -
Keymaris Tervuren €264,576 €338,901 1.4% -
AW Cardiologie Halle €297,130 €296,034 51.7% -
DR. TINE VAN BECELAERE Mechelen €269,436 €348,575 1.9% -
Barbara Deconinck, Endocrinologie-Diabetologie Langemark-Poelkapelle €287,482 €354,151 2.1% -
Dr. Julie Busschaert Bruges €265,003 €344,926 97.2% -

These companies have the same main activity as Dr. Kjell Van Royen: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €263,000 and €297,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 22-12-2020Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.313.818.6971730 Asse, registered on 22-12-2020
Financial year end
31 December
Peppol
Reachable since 05-11-2025
Company details

Annual accounts 2025

€282,056▼ 0.4%
Filing
Filed on 06-03-2026, 147 days before the end of the filing period
Financials

Insights on Dr. Kjell Van Royen

Dr. Kjell Van Royen files the micro format. That format states no turnover. The gross margin rose from -€1,745 in 2020 to €338,069 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Kjell Van Royen

What is the company number of Dr. Kjell Van Royen?
The company number of Dr. Kjell Van Royen is 0760.428.629. The VAT number is the same number with BE in front: BE 0760.428.629.
Where is Dr. Kjell Van Royen based?
The registered office is at Winkelbaan 36, 1730 Asse.Company details
What does Dr. Kjell Van Royen do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Kjell Van Royen?
Dr. Kjell Van Royen is a private limited company (BV).
When was Dr. Kjell Van Royen founded?
Dr. Kjell Van Royen was founded on 22-12-2020.
Is Dr. Kjell Van Royen still active?
Yes, Dr. Kjell Van Royen is an active enterprise in the KBO register.
What is the turnover of Dr. Kjell Van Royen?
The turnover in financial year 2025 is about €510,000. This figure is estimated from the gross margin of €338,069 and 31 comparable companies (NACE 86220). It probably lies between €450,000 and €710,000.Financials
Is Dr. Kjell Van Royen profitable?
In financial year 2025, Dr. Kjell Van Royen made a profit of €247,261.
Where can I find the annual accounts of Dr. Kjell Van Royen?
Dr. Kjell Van Royen filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Kjell Van Royen due?
Dr. Kjell Van Royen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.